The fate of the circulating C-terminal propeptide of type I procollagen (PICP) was studied. Trace amounts of 1251-PICP administered intravenously to rats disappeared from the blood with an initial ti of 6.1 min. After 45 min the radioactivity was distributed as follows: liver, 36 %; blood, 23 %; kidneys, 18 %; urine, 20 %2; spleen, 1 %; lungs, 2 %; heart, 0.4 %. To prevent escape of label from the site of uptake, PICP was labelled with '251-tyramine cellobiose (125I-TC), which is trapped intralysosomally. With this ligand a serum t-of 8.7 min was recorded, and 70 % and 20 % was traced in the liver and kidneys respectively. The uptake per liver endothelial cell (LEC) was 1000 times that per parenchymal cell and twice that per Kupffer cell. At I h and 6 h after addition of 125I-PICP to cultured LEC, 15% and 45 % respectively, had been endocytosed. Only ligands for the mannose receptor could compete with PICP for endocytosis. To study whether the same specificity was operative in vivo, 1251-PICP was injected along with an excess of ovalbumin, which is known to be endocytosed by the mannose receptor of LEC. The serum ti was prolonged from 6 to 16 min, signifying that terminal mannose residues are an important signal for clearance of PICP. In conclusion, these studies show that LEC constitute the main site of uptake of circulating PICP. The uptake is mediated by endocytic receptors which recognize terminal mannose residues.
INTRODUCTION
Type I collagen is the most abundant collagen species in many soft tissues and accounts for more than 90 % of the organic matrix of mineralized bone. It is synthesized in the form of a larger protein, type I procollagen, which contains relatively long additional sequences at both ends (Prockop et al., 1979a,b) . These sequences, known as the N-and C-terminal propeptides of type I procollagen, are removed by two specific proteinases in the extracellular space. Proper cleavage of the precursor-specific parts of the molecule is a prerequisite for the appropriate assembly of type I collagen molecules into collagen fibres (Miyahara et al., 1982) .
The C-terminal propeptide of type I procollagen (PICP), when cleaved off intact from the procollagen molecule, is found in free form in interstitial fluid, e.g. in healing wounds (Haukipuro et al., 1990) and also in blood, where its concentration is thought to reflect type I collagen synthesis in the body, especially by the skeleton (Parfitt et al., 1987) . However, for the correct interpretation of the concentration of PICP in blood, it would also be essential to know the routes along which this compound leaves the circulation.
The metabolic fate of several other connective tissue-derived substances in blood has recently been determined. These include hyaluronan, chondroitin sulphate, collagens, the laminin/nidogen complex and the N-terminal propeptide of type III procollagen (PIIINP), all of which are taken up, via at least three different receptor systems, by the endothelial cells of the liver (for a review, see .
The aim of the present study was to establish how PICP is cleared from the circulation. To this end, we studied the kinetics of clearance and organ distribution of radioiodinated PICP injected intravenously into rats. Our results suggest that uptake of PICP is another function of liver endothelial cells and is mediated via receptors that recognize terminal mannose residues.
MATERIALS AND METHODS

Chemicals and animals
Cellobiose, tyramine, cyanoborohydride, collagenase, cyanuric chloride, bovine serum albumin, ovalbumin, mannose, galactose, mannan and 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A.
[14C]Tyramine hydrochloride and Na125I were from Amersham International, Amersham, Bucks., U.K. and from Institutt for Energiteknikk, Kjeller, Norway. Fibronectin and human serum albumin were kindly donated by Kabi Vitrum AB, Stockholm, Sweden. Gelatinized type I collagen, prepared as described (Miller & Rhodes, 1982) , was kindly given by Dr. K. Rubin, University of Uppsala, Uppsala, Sweden. Hyaluronan (Healon) was obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. Culture medium RPMI 1640, supplemented with L-glutamine (2 mM), gentamicin (200 ,ug/ml) and fungizone (50 ,tg/ml), was purchased from Flow Laboratories, Irvine, Scotland, U.K. Hypnorm and Dormicum were from Janssen Pharmaceutica, Beerse, Belgium, and Hoffmann-LaRoche, Basel, Switzerland, respectively. Male Sprague-Dawley rats, fed on a standard diet and weighing about 200 g at the time of the study, were from Charles River, Fulzfeld, Germany.
Purification of PICP
Type I procollagen was first purified from the culture medium of human skin fibroblasts, essentially as described previously (Risteli & Risteli, 1987) . The procollagen was digested for 16 h at 30°C with highly purified bacterial collagenase (Worthington, grade CLSPA), using 0.3 mg of enzyme/litre of original medium volume. The C-terminal propeptide was purified from the digest by lectin affinity chromatography on concanavalin A-Sepharose (Pharmacia) in 50 mM-Tris/HCl buffer, pH 7.4, containing 0.5 M-NaCl, 10 mM-N-ethylmaleimide, 0 The method for preparation of pure cultures of functionally intact KC, LEC and PC from a single rat liver has been detailed elsewhere (Smedsr0d & Pertoft, 1985; Laakso & Smedsr0d, 1987) . Briefly, the liver was perfused with collagenase, and the resulting single cell suspension was subjected to velocity and density centrifugations to produce pure suspensions of PC and non-PC. Monolayer cultures of pure PC were established and maintained in fibronectin-coated dishes. The suspension of non-PC was a mixture of KC, LEC and stellate cells, and was essentially devoid of PC, red blood cells and debris. Seeding of this cell suspension into dishes coated with glutaraldehydetreated human albumin, followed by a 15 min incubation at 37°C, resulted in attachment and spreading of KC only. Un 
RESULTS
Trace amounts of 1251-PICP were injected intravenously into rats to investigate the circulatory survival and the anatomical distribution of this propeptide. Fig. 1 shows that the serum t. for the initial 10 min in this particular experiment was 6.2 min, which could be calculated from the semi-logarithmic plot (inset of Fig. 1) . Two experiments, including the one presented as Fig.  1 , gave a mean ti of 6.1 min. Acid-soluble '25I-labelled material started to appear in the blood after 10 min (Fig. 1) . The anatomical distribution of the label, obtained by measuring the radioactivity in various organs 45 min after injection (Fig. 2) , gives the impression of highest uptake activity in liver and (Pertoft & Smedsr0d, 1987) .
kidneys (36 % and 18 % of recovered label respectively), whereas the content in blood and urine amounted to 23 % and 20% respectively. Uptake in spleen, heart and lungs was as low as about 3.5 % combined. Due to effective degradation ofeliminated propeptide, and therefore escape of label from the site of uptake, it is unlikely that the anatomical distribution recorded after 45 min correctly reflects the relative importance of these organs in the sequestration of PICP. To overcome the problem of release of label after uptake and degradation, PICP was labelled with 125I-TC, which is trapped intralysosomally after hydrolysis of the carrier PICP. Following intravenous administration of PICP labelled in this manner, a mean t. of 8.7 min (S.D. = 0.9; n = 6) was recorded. The results of a typical experiment are shown in Fig. 3 . Small 251I-labelled degradation products could not be detected in the blood at any time point. Analysis ofthe anatomical distribution revealed that with this ligand the liver contained nearly 70 % of the recovered radioactivity, whereas about 20 % was taken up in the kidneys (Fig. 4) for 4 h at 37°C in 3.5 cm diameter dishes containing 2.5 x 106 cells and 600 ,sl of medium without inhibitors (a), or in the presence of unlabelled gelatinized type I collagen (10 ug/ml) (b); hyaluronan (10,cg/ml) (c); 50 mM-galactose (d); 50 mM-mannose (e); mannan
(1 mg/ml) (f); mannan (100 /sg/ml) (g); mannan (10 isg/ml) (h); or mannan 1 /sg/ml (i). El, Cell-associated radioactivity; M., acidsoluble radioactivity. Results, given as percentages of total radioactivity, are means of triplicate measurements.
125I-TC-PICP revealed that most of the label was taken up by LEC. One-third was recovered in KC, whereas only negligible amounts were found in PC. The uptake per LEC was 1000 times that per PC, and twice that per KC (Fig. 5) . Since the relative cell number distribution in rat liver is 69 % PC, 22 % LEC and 9 % KC (Smedsr0d & Pertoft, 1987) , it could be estimated that the uptake per cell population in the intact liver was 81 % in LEC, 17% in KC and 2.5% in PC.
For more controlled studies of the kinetics and specificity of uptake, pure monolayer cultures of LEC were established. Trace amounts of 1251-PICP added to the cultures were taken up at a constant rate during the first 4 h; thereafter the rate slowed down (Fig. 6) . After 20 h, more than 60 % of the added ligand had been endocytosed. Degradation was very effective, as shown by the observation that most of the endocytosed ligand was degraded already after 1 h of incubation.
To study the specificity of endocytosis, 1251-PICP was added to the cultures along with an excess of various unlabelled substances known to bind to different endocytosis receptors on LEC. The results show that only mannose (50 mM) or mannan ( 1O ,ug/ml) could significantly inhibit endocytosis and degradation of the propeptide (Fig. 7) . Galactose (50 mM) was only slightly in- (50Omg) were injected through the tail vein of a rat, and radioactivity in blood samples taken at various time points was plotted against time after injection. Results from two experiments are plotted. See the legend to Fig. l for additional explanation. The serum tl (calculated from the slope of the inset) was 16 min.
hibitory, whereas neither gelatinized type I collagen (1O /sg/ml) nor hyaluronan (1O jug/ml), both ofwhich are avidly endocytosed via specific receptors on LEC, could inhibit the uptake. These findings suggest that PICP is endocytosed by LEC mainly via mannose receptors. To establish whether this also holds for the situation in vivo, 125I_pJCp was injected intravenously into rats along with an excess amount of ovalbumin (initial blood concentration about 3 mg/ml), which is known to be taken up mainly by the mannose receptor of LEC in vivo (Smedsr0d & Einarsson, 1990) . The results from two such experiments showed that under these conditions the serum ti of the propeptide increased to about 16 min (Fig. 8) , suggesting that the mannose receptor on LEC is indeed responsible for the clearance of circulating PICP in vivo.
DISCUSSION
Based on the notion that the serum level of connective tissue components directly mirrors the release of these substances from the connective tissue, it was first believed that measurement of such molecules in serum would serve as a sensitive non-invasive means to diagnose disorders in which abnormal production or destruction of connective tissue is involved. This view has been modified by the finding that the LEC efficiently eliminate not only hyaluronan (Smedsr0d et al., 1984) and PIIINP (Smedsr0d, 1988) , but also chondroitin sulphate (Smedsr0d et al., 1985a) , gelatinized collagens (Smedsr0d et al., 1985b; Smedsr0d, 1989) and laminin/nidogen . High-affinity binding mechanisms on LEC recognize these molecules in three distinct groups: (1) hyaluronan and chondroitin sulphate/ chondroitin sulphate proteoglycans; (2) gelatinized collagens; (3) PIIINP (for a review, see . Receptors for endocytosis of IgG-immune complexes (Fc-receptor) and mannose-terminated glycoconjugates, both of which are present on LEC, are not involved in the uptake of these connective tissue macromolecules. The specificity of endocytosis of laminin/ nidogen is as yet unknown.
The serum ti of intravenously injected PICP labelled with 1251
in the phenyl nAngs of the aromatic amino acids was found to be 6.1 min, which is significantly longer than the serum ti values observed for the other connective tissue macromolecules taken 1990 up by these cells (Dahl et al., 1988; Smedsr0d etal., 1989 In order to carry out controlled studies on the kinetics and the specificity of endocytosis of the propeptide, pure monolayer cultures of LEC were given 125I-PICP, and cells and media were analysed for the presence of intact or degraded ligand. If no inhibitors were present, the cells took up and degraded the ligand at an initial speed (during the first 3-4 h of incubation) corresponding to a clearance efficiency of about 0.4 pl of medium/min per cell. Thus a considerably lower rate of uptake was observed for PICP than for any other of the major connective tissue macromolecules known to be taken up by receptormediated endocytosis by LEC in vitro (Smedsr0d et al., 1986) . This explains the comparatively long serum ti observed in vivo for this propeptide. The clearance efficiency decreased with a prolonged time of incubation, and after 20 h the uptake had levelled off when about 60 % of added ligand had been endocytosed, probably due to lowering of ligand concentration and exhaustion of the cells. The same phenomenon has been reported for the endocytosis of hyaluronan in cultured LEC (Smedsr0d et al., 1984) . Degradation proceeds very effectively, as indicated by the observation that the cell-associated radioactivity peaked at about 6 % after 1-2 h of incubation, and decreased thereafter.
Inhibition experiments with cultured LEC revealed that mannose (50 mM) and mannan (1 mg/ml) inhibited endocytosis of 1251-PICP by about 75 %. No inhibition was observed with gelatinized type I collagen, hyaluronan or galactose when used in concentrations sufficiently high to effectively compete for binding to their respective receptors on LEC and PC. These results support the idea that the mannose receptor on LEC represents the main mechanism of uptake of circulating PICP. To test this hypothesis, 1251-PICP was administered intravenously along with high amounts of ovalbumin, which is known to be avidly endocytosed by LEC via the mannose receptor (Smedsr0d & Einarsson, 1990) . Monitoring the disappearance of label from the circulation revealed that the ti was increased by a factor of almost three. This observation, along with the results from the specificity experiments in vitro, strongly suggests that the propeptide is removed from the blood by means of endocytosis mainly via mannose receptors on LEC.
Recent research has assigned major scavenger functions to the population of LEC ). The list of major connective tissue-derived macromolecules cleared by these cells is now extended by PICP, which is endocytosed via the mannose receptor. Uptake of a connective tissue macromolecule via this particular receptor has not been reported until now. Since the mannose receptor recognizes mannose only if it is positioned in the terminal end of the carbohydrate side chain, our result fits well with the findings of Clark & Kefalides (1976) and Clark (1979) that the propeptide contains covalently linked highmannose-type oligosaccharide, one branch per polypeptide chain.
The serum ti of PICP was found to be 6.1-8.7 min. Although this reflects an effective mechanism of clearance, it is considerably slower than the serum t. reported for hyaluronan (t, = 0.9 min; Dahl et al., 1988) , gelatinized collagens (t1 = 2.2 min; Smedsr0d, 1989) , and PIIINP (t2 = 2 min; Smedsr0d, 1988) . This implies that increased serum levels of hyaluronan and PIIINP, which have been taken as signs of ongoing hepatic fibrosis or connective tissue diseases elsewhere in the body, can actually more easily indicate an insufficient uptake function in LEC, whereas increased serum levels of PICP may serve as a better marker for an increased production of connective tissue.
This study was carried out with rats only. Therefore it may be argued that our findings do not necessarily apply to humans. Nevertheless, data from work with LEC from other species, including humans, signify the same morphology and functional properties of the cells. Moreover, since the recognized substance, namely terminal mannose, is not a species-specific structure, it is highly probable that what we have found in rat concerning the uptake of circulating PICP applies to humans as well.
